HPV Vaccine Safety and Efficacy Issues: by Dr. Tomljenovic, Vancouver, 2015

Should the CDC and Merck’s claims of efficacy and safety about Gardasil be accepted without scrutiny? Dr. Tomljenovic explores available data suggesting that there is no indication for this vaccine in the setting of Pap smear efficacy, that claims of vaccine efficacy are without an evidence base, and that risks including death and permanent disability have a known scientific mechanism. She asks, “Is it ethical to put young women at risk of death or a disabling autoimmune disease at a pre-adolescent age, for a vaccine that has not yet prevented a single case of cervical cancer, a disease that may develop 20-30 years after exposure to HPV, when the same can be prevented with regular Pap screening which carries no risks?”